{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:40:41Z","timestamp":1792104041799,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T00:00:00Z","timestamp":1542067200000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["127106-PF-14-254-01-TBE"],"award-info":[{"award-number":["127106-PF-14-254-01-TBE"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005963","name":"LAM Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005963","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Engles"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-HL118760"],"award-info":[{"award-number":["R01-HL118760"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P01-CA120964"],"award-info":[{"award-number":["P01-CA120964"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R35-CA197459"],"award-info":[{"award-number":["R35-CA197459"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancercell.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ccell.2017.09.013","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T15:00:31Z","timestamp":1508425231000},"page":"624-638.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":155,"title":["mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability"],"prefix":"10.1016","volume":"32","author":[{"given":"Alexander J.","family":"Valvezan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Belaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilaire C.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer K.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly C.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Baglini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin E.","family":"Housden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Perrimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Kwiatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Asara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth P.","family":"Henske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan D.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2017.09.013_bib1","doi-asserted-by":"crossref","first-page":"e31900","DOI":"10.1371\/journal.pone.0031900","article-title":"Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC)","volume":"7","author":"Auricchio","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2017.09.013_bib2","doi-asserted-by":"crossref","first-page":"12587","DOI":"10.18632\/oncotarget.3494","article-title":"Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer","volume":"6","author":"Barfeld","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2017.09.013_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/0471143030.cb0340s49","article-title":"Purification of ribosomes from human cell lines","volume":"Chapter 3","author":"Belin","year":"2010","journal-title":"Curr. Protoc. Cell Biol."},{"key":"10.1016\/j.ccell.2017.09.013_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ceb.2017.02.012","article-title":"mTORC1 signaling and the metabolic control of cell growth","volume":"45","author":"Ben-Sahra","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ccell.2017.09.013_bib5","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1126\/science.1228792","article-title":"Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1","volume":"339","author":"Ben-Sahra","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ccell.2017.09.013_bib6","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.aad0489","article-title":"mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle","volume":"351","author":"Ben-Sahra","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ccell.2017.09.013_bib7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2017.09.013_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1158\/2159-8290.CD-16-0611","article-title":"Adaptive reprogramming of de novo pyrimidine synthesis is a metabolic vulnerability in triple-negative breast cancer","volume":"7","author":"Brown","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2017.09.013_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1349-7006.1990.tb02546.x","article-title":"Evaluation of mizoribine as an immunosuppressant in subrenal capsule assay using immunocompetent mice","volume":"81","author":"Chen","year":"1990","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.ccell.2017.09.013_bib10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1432-1033.1995.tb20498.x","article-title":"5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?","volume":"229","author":"Corton","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ccell.2017.09.013_bib11","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cell.2014.03.052","article-title":"Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer","volume":"157","author":"Cunningham","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2017.09.013_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/ncb2763","article-title":"Signal integration by mTORC1 coordinates nutrient input with biosynthetic output","volume":"15","author":"Dibble","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ccell.2017.09.013_bib13","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/0008-5472.CAN-10-1728","article-title":"Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth","volume":"71","author":"Drygin","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2017.09.013_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"Duvel","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2017.09.013_bib15","doi-asserted-by":"crossref","first-page":"e12179","DOI":"10.1371\/journal.pone.0012179","article-title":"Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells","volume":"5","author":"Fellenberg","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2017.09.013_bib16","doi-asserted-by":"crossref","first-page":"38099","DOI":"10.18632\/oncotarget.17485","article-title":"Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R","volume":"8","author":"Filippakis","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2017.09.013_bib17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ccell.2017.09.013_bib18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd4204","article-title":"PI3K and cancer: lessons, challenges and opportunities","volume":"13","author":"Fruman","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2017.09.013_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2049-3002-1-3","article-title":"Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth","volume":"1","author":"Griffiths","year":"2013","journal-title":"Cancer Metab."},{"key":"10.1016\/j.ccell.2017.09.013_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1541-7786.MCR-12-0605","article-title":"Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis","volume":"11","author":"Guo","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ccell.2017.09.013_bib21","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1021\/ml300110s","article-title":"Discovery of CX-5461, the first direct and selective inhibitor of RNA polymerase I, for cancer therapeutics","volume":"3","author":"Haddach","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ccell.2017.09.013_bib22","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0006-2952(95)00026-V","article-title":"Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding","volume":"49","author":"Hager","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ccell.2017.09.013_bib23","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00384-009-0759-2","article-title":"Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis","volume":"24","author":"He","year":"2009","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.ccell.2017.09.013_bib24","doi-asserted-by":"crossref","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ccell.2017.09.013_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0303-7207(02)00230-7","article-title":"Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells","volume":"196","author":"Hodges","year":"2002","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.ccell.2017.09.013_bib26","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/MCB.00289-08","article-title":"The TSC1-TSC2 complex is required for proper activation of mTOR complex 2","volume":"28","author":"Huang","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2017.09.013_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.semcdb.2014.08.004","article-title":"mTORC1 signaling controls multiple steps in ribosome biogenesis","volume":"36","author":"Iadevaia","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ccell.2017.09.013_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.trecan.2016.03.008","article-title":"Emerging role of mTOR in the response to cancer therapeutics","volume":"2","author":"Ilagan","year":"2016","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ccell.2017.09.013_bib29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2174\/092986730607220401123549","article-title":"Mizoribine and mycophenolate mofetil","volume":"6","author":"Ishikawa","year":"1999","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ccell.2017.09.013_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5500\/wjt.v2.i4.51","article-title":"Current state of renal transplant immunosuppression: present and future","volume":"2","author":"Kalluri","year":"2012","journal-title":"World J. Transplant"},{"key":"10.1016\/j.ccell.2017.09.013_bib31","first-page":"4210","article-title":"Adenine phosphoribosyltransferase deficiency in cultured mouse mammary tumor FM3A cells resistant to 4-carbamoylimidazolium 5-olate","volume":"42","author":"Koyama","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2017.09.013_bib32","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1016\/0006-2952(83)90301-5","article-title":"Genetic and biochemical studies on the activation and cytotoxic mechanism of bredinin, a potent inhibitor of purine biosynthesis in mammalian cells","volume":"32","author":"Koyama","year":"1983","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ccell.2017.09.013_bib33","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1056\/NEJMcibr1406613","article-title":"Molecular basis of giant cells in tuberous sclerosis complex","volume":"371","author":"Kwiatkowski","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2017.09.013_bib34","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1093\/nar\/gkv047","article-title":"Regulation of mammalian nucleotide metabolism and biosynthesis","volume":"43","author":"Lane","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2017.09.013_bib35","doi-asserted-by":"crossref","first-page":"e2722","DOI":"10.1371\/journal.pone.0002722","article-title":"Global regulation of nucleotide biosynthetic genes by c-Myc","volume":"3","author":"Liu","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2017.09.013_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrm2672","article-title":"Molecular mechanisms of mTOR-mediated translational control","volume":"10","author":"Ma","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2017.09.013_bib37","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1172\/JCI200318384","article-title":"Azathioprine: old drug, new actions","volume":"111","author":"Maltzman","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2017.09.013_bib38","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.4161\/cc.6390","article-title":"Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells","volume":"7","author":"Mannava","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ccell.2017.09.013_bib39","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1158\/2159-8290.CD-16-0612","article-title":"PTEN regulates glutamine flux to pyrimidine synthesis and sensitivity to dihydroorotate dehydrogenase inhibition","volume":"7","author":"Mathur","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2017.09.013_bib40","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1038\/sj.onc.1209883","article-title":"Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases","volume":"25","author":"Mayer","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2017.09.013_bib41","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1128\/MCB.00319-10","article-title":"mTORC1 directly phosphorylates and regulates human MAF1","volume":"30","author":"Michels","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2017.09.013_bib42","doi-asserted-by":"crossref","first-page":"39517","DOI":"10.1074\/jbc.M605121200","article-title":"RPA2 is a direct downstream target for ATR to regulate the S-phase checkpoint","volume":"281","author":"Olson","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2017.09.013_bib43","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.1228771","article-title":"Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis","volume":"339","author":"Robitaille","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ccell.2017.09.013_bib44","doi-asserted-by":"crossref","first-page":"798","DOI":"10.7164\/antibiotics.28.798","article-title":"Effect of bredinin and its aglycone on L5178Y cells","volume":"28","author":"Sakaguchi","year":"1975","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.ccell.2017.09.013_bib45","first-page":"1643","article-title":"Action of bredinin on mammalian cells","volume":"35","author":"Sakaguchi","year":"1975","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2017.09.013_bib46","doi-asserted-by":"crossref","first-page":"15380","DOI":"10.1074\/jbc.M109.071639","article-title":"Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells","volume":"285","author":"Shor","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2017.09.013_bib47","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, metabolism, and cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2017.09.013_bib48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2125.2006.02779.x","article-title":"Safety, tolerability and pharmacokinetics of higher-dose mizoribine in healthy male volunteers","volume":"63","author":"Stypinski","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ccell.2017.09.013_bib49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2739\/kurumemedj.38.195","article-title":"A sequential immunosuppressive treatment with mizoribin (Bredinin) plus cyclosporin A on the subrenal capsule assay","volume":"38","author":"Ushijima","year":"1991","journal-title":"Kurume Med. J."},{"key":"10.1016\/j.ccell.2017.09.013_bib50","doi-asserted-by":"crossref","first-page":"44289","DOI":"10.18632\/oncotarget.6247","article-title":"The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in\u00a0vivo","volume":"6","author":"Vendetti","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2017.09.013_bib51","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2017.09.013_bib52","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1101\/gad.198630.112","article-title":"Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress","volume":"27","author":"Young","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccell.2017.09.013_bib53","doi-asserted-by":"crossref","first-page":"L694","DOI":"10.1152\/ajplung.00204.2003","article-title":"Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways","volume":"286","author":"Yu","year":"2004","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ccell.2017.09.013_bib54","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1073\/pnas.0810790106","article-title":"Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells","volume":"106","author":"Yu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2017.09.013_bib55","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nprot.2012.024","article-title":"A positive\/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue","volume":"7","author":"Yuan","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ccell.2017.09.013_bib56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncb2897","article-title":"Causes and consequences of replication stress","volume":"16","author":"Zeman","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ccell.2017.09.013_bib57","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI200317222","article-title":"Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR","volume":"112","author":"Zhang","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2017.09.013_bib58","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nature13492","article-title":"Coordinated regulation of protein synthesis and degradation by mTORC1","volume":"513","author":"Zhang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2017.09.013_bib59","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12032-014-0373-1","article-title":"Elevated expression of IMPDH2 is associated with progression of kidney and bladder cancer","volume":"32","author":"Zou","year":"2015","journal-title":"Med. Oncol."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610817304178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610817304178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T18:15:15Z","timestamp":1659636915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610817304178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1535610817304178"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2017.09.013","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732024481.793538415","asserted-by":"object"}]},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2017.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}